A number of other research firms have also weighed in on NUS. Zacks Investment Research lowered Inflarx from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Deutsche Bank lowered Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 price objective for the company. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Stifel Nicolaus set a $99.00 price objective on C.H. Robinson Worldwide and gave the stock a “hold” rating in a research note on Monday, March 25th. Finally, Bank of America dropped their price objective on Canopy Growth from $80.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday, June 19th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. Nu Skin Enterprises currently has an average rating of “Hold” and an average price target of $73.13.
NYSE NUS opened at $45.07 on Friday. The company has a market capitalization of $2.47 billion, a price-to-earnings ratio of 12.80, a price-to-earnings-growth ratio of 1.02 and a beta of 0.74. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.10 and a current ratio of 1.86. The stock has a 50-day simple moving average of $48.46. Nu Skin Enterprises has a twelve month low of $44.36 and a twelve month high of $88.68.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. The firm had revenue of $623.60 million during the quarter, compared to analyst estimates of $615.98 million. Nu Skin Enterprises had a return on equity of 26.81% and a net margin of 4.82%. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.79 earnings per share. On average, sell-side analysts forecast that Nu Skin Enterprises will post 3.92 earnings per share for the current fiscal year.
A number of institutional investors have recently made changes to their positions in NUS. NumerixS Investment Technologies Inc bought a new position in Nu Skin Enterprises in the fourth quarter valued at approximately $108,000. Great West Life Assurance Co. Can lifted its stake in Nu Skin Enterprises by 4.9% in the fourth quarter. Great West Life Assurance Co. Can now owns 33,463 shares of the company’s stock valued at $1,902,000 after buying an additional 1,556 shares in the last quarter. United Services Automobile Association lifted its stake in Nu Skin Enterprises by 2.0% in the fourth quarter. United Services Automobile Association now owns 14,448 shares of the company’s stock valued at $886,000 after buying an additional 277 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Nu Skin Enterprises by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,132,318 shares of the company’s stock valued at $69,442,000 after buying an additional 38,282 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Nu Skin Enterprises by 7.3% in the fourth quarter. Geode Capital Management LLC now owns 547,265 shares of the company’s stock valued at $33,563,000 after buying an additional 37,229 shares in the last quarter. 77.17% of the stock is owned by institutional investors.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Recommended Story: What is the NASDAQ Stock Market?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.